Blanket Purchase Agreement HT001420A0025
Award Date
2/26/20
Last Date to Order
2/26/25
Federal Agency
Defense Health Agency
Awardee
Ark Diagnostics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Health Agency awarded a blanket purchase agreement to Qiagen, LLC for reagents, consumables, and related laboratory supplies. The single award BPA has a potential value of $8 million and a period of performance through February 2025. Two firm fixed price call contracts were subsequently awarded against the BPA, the first for $60,041 worth of reagents and peripherals consumables to be delivered to Bethesda, Maryland by September 2021. The second call contract was for $125,000 of...
The Defense Health Agency has awarded a single-award Blanket Purchase Agreement (BPA) contract to Polyscientific Research and Development Corporation, a leading manufacturer of chemicals, stains, and reagents for in vitro diagnostic testing. The $8 million BPA contract, with a period of performance through September 2026, provides the agency with an efficient mechanism to procure a wide range of reagents and consumable supplies to support its medical testing and research programs.
Specific...
The Defense Health Agency (DHA) has awarded a $7.5 million Blanket Purchase Agreement (BPA) to One Lambda, Inc., a for-profit manufacturer of medical testing reagents and diagnostic kits. The BPA serves as a master ordering vehicle for laboratory supplies to support federal healthcare and research initiatives across multiple agencies, including the Department of Health and Human Services (HHS) National Institutes of Health (NIH), Department of Veterans Affairs (VA), and Department of Defense...
The Defense Health Agency awarded Promega Corporation an indefinite delivery vehicle in the form of a blanket purchase agreement valued at up to $11.5 million. The BPA enables the agency to place fixed price calls for DNA analysis equipment, reagents, and related products to support its biomedical research and healthcare programs.
Between September 2020 and the present date, the agency has exercised this BPA to award Promega eight calls valued between $816 and $261,323.68 each. The calls...
Roche Diagnostics Corporation has been awarded a single award blanket purchase agreement by the Defense Health Agency to provide laboratory testing reagents and a cell stainer. The potential value of the BPA is $129,021.70 through April 2024.
A firm fixed price call was placed against the BPA for $15,314.77 to supply reagents supporting DHA programs. The reagents will be delivered to a facility in Castleton, Indiana with performance through September 2023. As the prime contractor, Roche...
The Defense Health Agency (DHA) awarded a $5.3 million single-award Blanket Purchase Agreement (BPA) to Biodiscovery LLC, doing business as Daicel Arbor Biosciences, a foreign-owned, for-profit manufacturer of specialized genomic and proteomic research tools and services. The BPA, which runs through September 2027, enables DHA to issue firm-fixed-price delivery orders for custom DNA reagents, MYBAITS reagents, and other proprietary genomic products to support the agency's biomedical research...
The Defense Health Agency awarded a blanket purchase agreement to Roche Diagnostics Corporation with a potential value of $20 million. The BPA will facilitate orders for COVID-19 test kits and medical supplies to support the Agency's testing, research, and healthcare programs.
Task orders issued against the BPA indicate Roche will provide reagents, test kits, consumables, diagnostic equipment, and laboratory supplies from its facilities in Bethesda, Maryland and Castleton, Indiana. Orders...
Abbott Laboratories Inc., Abbott Diagnostics Division was awarded a blanket purchase agreement (BPA) by the Defense Health Agency to provide clinical chemistry and immunoassay testing services. The BPA establishes a single award agreement with a potential value of $1,250,000 to streamline procurement of these critical laboratory diagnostic services over its period of performance from July 1, 2023 through April 30, 2024.
Three firm fixed price BPA call contracts were issued against this BPA to...
The U.S. Department of Veterans Affairs (VA) and Defense Health Agency (DHA) have awarded a Blanket Purchase Agreement (BPA) contract to The Binding Site, Inc., a medical diagnostics company, for the provision of reagents, supplies, and specialized laboratory equipment. The contract, valued at $1.47 million, has a period of performance through March 2026 and does not utilize any set-asides.
The Binding Site, Inc. will provide optilite analyzers, free kappa/lambda light chain assay kits,...
The Blanket Purchase Agreement was awarded as a single award by the Defense Health Agency to Agilent Technologies Inc. on November 22, 2022. The potential value of the contract is $1.1 million. Under the terms of the agreement, Agilent will provide reagents and consumables in support of the Defense Health Agency's laboratory needs through November 21, 2027.
The purpose of the Blanket Purchase Agreement is to establish an efficient means by which the Defense Health Agency can procure reagents...